Similar articles

• Editorial comment on: Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.

  Eden CG. Eden CG. Eur Urol. 2009 May;55(5):1143. doi: 10.1016/j.eururo.2008.08.052. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18783871 Clinical Trial. No abstract available.
• Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.

  Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, Pettaway CA, Pisters LL, Swanson DA, Madsen LT, Huber N, Troncoso P, Babaian RJ, Wood CG. Davis JW, et al. Eur Urol. 2009 May;55(5):1135-43. doi: 10.1016/j.eururo.2008.08.051. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18783876 Free PMC article. Clinical Trial.
• Impact of unilateral sural nerve graft on recovery of potency and continence following radical prostatectomy: 3-year longitudinal study.

  Namiki S, Saito S, Nakagawa H, Sanada T, Yamada A, Arai Y. Namiki S, et al. J Urol. 2007 Jul;178(1):212-6; discussion 216. doi: 10.1016/j.juro.2007.03.043. Epub 2007 May 17. J Urol. 2007. PMID: 17499797
• [Cavernous nerve reconstruction to restore erectile function following radical prostatectomy].

  Song LJ, Pan LJ, Xu YM. Song LJ, et al. Zhonghua Nan Ke Xue. 2006 Oct;12(10):939-42. Zhonghua Nan Ke Xue. 2006. PMID: 17121030 Review. Chinese.
• Strategies to promote recovery of cavernous nerve function after radical prostatectomy.

  Burnett AL. Burnett AL. World J Urol. 2003 May;20(6):337-42. doi: 10.1007/s00345-002-0303-2. Epub 2002 Dec 10. World J Urol. 2003. PMID: 12811492 Review.